EFFECT OF TREATMENT W/ AZITHROMYCIN W/ UNSTABLE ANGINA/ACUTE MI

阿奇霉素治疗不稳定型心绞痛/急性心肌梗死的效果

• 批准号: 6306570
• 负责人: BOJAN CERCEK
• 金额: $ 0.1万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-12-01 至 2000-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6306570
• 关键词: angina pectoris; azithromycin; clinical research; disease /disorder prevention /control; drug screening /evaluation; heart disorder chemotherapy; human subject; human therapy evaluation

Patients who are admitted with rest angina are treated with a short 5-day treatment with Azithromycin. Azithromycin is an antibiotic, FDA approved and widely used for the treatment of the respiratory infections with Chlamydia pneunomiae. All other medications and treatment for the patients will be deemed necessary by the admitting physician. These patients are followed for six months and determined whether the treatment with Azithromycin prevents new coronary events.

休息性心绞痛患者入院时接受阿奇霉素短时间5天治疗。 阿奇霉素是一种抗生素，FDA批准并广泛用于治疗肺炎衣原体的呼吸道感染。 所有其他药物和治疗的病人将被视为必要的入院医生。 这些患者被随访6个月，并确定阿奇霉素治疗是否能预防新的冠状动脉事件。